The Express Gene™ Non-Invasive Prenatal Screening (NIPS/NIPT) offers expectant parents a safe and effective way to screen for chromosomal abnormalities in their unborn baby. By analyzing cell-free fetal DNA present in the mother’s bloodstream, this advanced test can detect conditions such as Down syndrome, Edwards syndrome, and Patau syndrome early in the pregnancy. This screening provides crucial insights into the baby’s health, allowing parents and healthcare providers to make informed decisions and prepare accordingly.
Our NIPS/NIPT test provides a highly accurate detection of chromosomal abnormalities without the need for invasive procedures such as amniocentesis or chorionic villus sampling (CVS), which carry risks of miscarriage. By utilizing a simple blood draw from the mother, this test ensures the safety and comfort of both the mother and the baby. The non-invasive nature of the test, combined with its high sensitivity and specificity, makes it a reliable choice for early prenatal screening, giving expectant parents peace of mind and the information needed to plan for a healthy pregnancy.
Customize your order and select preferred genes
$350.00
© 2024 ExpressGene. All rights reserved. Unless otherwise indicated, all product names, service names, and logos featured on this website are trademarks owned by ExpressGene, its subsidiaries, or its affiliates. Any use of ExpressGene trademarks, trade names, or trade dress on this website must be authorized in writing by ExpressGene, except for the purpose of identifying ExpressGene’s products or services.